GLYCOBIOME Trademark

Trademark Overview


On Thursday, March 5, 2015, a trademark application was filed for GLYCOBIOME with the United States Patent and Trademark Office. The USPTO has given the GLYCOBIOME trademark a serial number of 86554584. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 21, 2016. This trademark is owned by VL32, Inc.. The GLYCOBIOME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Genetic testing for scientific research purposes; Genetic testing for medical purposes; scientific and technological services, including acquisition, collection, analysis, compilation, electronic storage and distribution of metagenomic, metaproteomic, metatranscriptomic, and metabolomic data and related clinical, agricultural, and veterinary data for treatment and diagnostic purposes of humans, animals, and plants; development of computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, and metabolomic data, including patient clinical care information, veterinary care information, agricultural data, and medical research data; chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic service bacteriological, virological, fungal, protistal, and molecular diagnostic services; acquisition, collection, analysis, compilation, storage a...
glycobiome

General Information


Serial Number86554584
Word MarkGLYCOBIOME
Filing DateThursday, March 5, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 21, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesGenetic testing for scientific research purposes; Genetic testing for medical purposes; scientific and technological services, including acquisition, collection, analysis, compilation, electronic storage and distribution of metagenomic, metaproteomic, metatranscriptomic, and metabolomic data and related clinical, agricultural, and veterinary data for treatment and diagnostic purposes of humans, animals, and plants; development of computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools for genomic, proteomic, transcriptomic, and metabolomic data, including patient clinical care information, veterinary care information, agricultural data, and medical research data; chemical, biochemical, and molecular diagnostic services, including chemical, immunological, and microbiological diagnostic service bacteriological, virological, fungal, protistal, and molecular diagnostic services; acquisition, collection, analysis, compilation, storage and distribution of biological samples, including microbial and tissue samples; diagnostic services for assessing health and determining treatment for metabolism, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; scientific research in the field of genetics, genetic engineering of microbes, and molecular testing; Research and development in the pharmaceutical and biotechnology fields; microbial and anti-microbial preparations and substances for pharmaceutical, veterinary and medical purposes for use in the treatment of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; dietary supplements, nutritional supplements, nutraceuticals, food supplements, beverages, nutritional food bars, and animal feed or feed supplements containing microorganisms for medical, veterinary, therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment or prevention of metabolic disorders, diabetes, obesity, cardiovascular disease, malnutrition, short bowel syndrome, frailty, autism, allergy, atopy, neurological disorders, chronic or acute inflammatory diseases, inflammatory bowel disease, diverticulitis, non-alcoholic steatohepatitis, infection, susceptibility to infection, colonization with drug-resistant organisms, fertility, aging, cancer, and autoimmune diseases; therapeutics, consumer products and articles, including moisturizers, creams, lotions, gels, toners, cleansers, bandages, and cosmetics, pharmaceutical, veterinary and medical preparations and substances diagnostic kits and diagnostic reagents; diagnostics and tools for medical purposes; instruments, supplies and disposables; computer databases and computer-readable programs, software, and scientific, analytical, and statistical tools

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 18, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVL32, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Thursday, January 21, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, January 21, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 19, 2016ASSIGNED TO EXAMINER
Friday, June 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 12, 2015NON-FINAL ACTION E-MAILED
Friday, June 12, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 10, 2015ASSIGNED TO EXAMINER
Wednesday, March 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM